Anti-FGFP2/ FGFBP2/ HBP17RP functional antibody

Anti-FGFP2/ FGFBP2/ HBP17RP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FGFBP2/FGFBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0924-Ab-1/ GM-Tg-hg-SE0924-Ab-2Anti-Human FGFBP2 monoclonal antibodyHuman
GM-Tg-rg-SE0924-Ab-1/ GM-Tg-rg-SE0924-Ab-2Anti-Rat FGFBP2 monoclonal antibodyRat
GM-Tg-mg-SE0924-Ab-1/ GM-Tg-mg-SE0924-Ab-2Anti-Mouse FGFBP2 monoclonal antibodyMouse
GM-Tg-cynog-SE0924-Ab-1/ GM-Tg-cynog-SE0924-Ab-2Anti-Cynomolgus/ Rhesus macaque FGFBP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0924-Ab-1/ GM-Tg-felg-SE0924-Ab-2Anti-Feline FGFBP2 monoclonal antibodyFeline
GM-Tg-cang-SE0924-Ab-1/ GM-Tg-cang-SE0924-Ab-2Anti-Canine FGFBP2 monoclonal antibodyCanine
GM-Tg-bovg-SE0924-Ab-1/ GM-Tg-bovg-SE0924-Ab-2Anti-Bovine FGFBP2 monoclonal antibodyBovine
GM-Tg-equg-SE0924-Ab-1/ GM-Tg-equg-SE0924-Ab-2Anti-Equine FGFBP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0924-Ab-1/ GM-Tg-hg-SE0924-Ab-2; GM-Tg-rg-SE0924-Ab-1/ GM-Tg-rg-SE0924-Ab-2;
GM-Tg-mg-SE0924-Ab-1/ GM-Tg-mg-SE0924-Ab-2; GM-Tg-cynog-SE0924-Ab-1/ GM-Tg-cynog-SE0924-Ab-2;
GM-Tg-felg-SE0924-Ab-1/ GM-Tg-felg-SE0924-Ab-2; GM-Tg-cang-SE0924-Ab-1/ GM-Tg-cang-SE0924-Ab-2;
GM-Tg-bovg-SE0924-Ab-1/ GM-Tg-bovg-SE0924-Ab-2; GM-Tg-equg-SE0924-Ab-1/ GM-Tg-equg-SE0924-Ab-2
Products NameAnti-FGFBP2 monoclonal antibody
Formatmab
Target NameFGFBP2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FGFBP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0924-Ag-1Recombinant multi-species FGFP2/ FGFBP2/ HBP17RP protein
    CytokineGM-Tg-g-SE0924-Ag-1fibroblast growth factor binding protein 2 (FGFBP2) protein


    Target information

    Target IDGM-SE0924
    Target NameFGFBP2
    Gene ID83888,714554
    Gene Symbol and SynonymsFGFBP2,HBP17RP,KSP37
    Uniprot AccessionQ9BYJ0
    Uniprot Entry NameFGFP2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000137441
    Target ClassificationN/A

    The target: FGFBP2, gene name: FGFBP2, also named as HBP17RP, KSP37. This gene encodes a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma.[provided by RefSeq Staff, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.